Copyright
©The Author(s) 2021.
World J Hepatol. May 27, 2021; 13(5): 571-583
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.571
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.571
Figure 4 Survival rates.
A: Albumin concentration (albumin ≥ 3.8 g/dL vs 3.5-3.7 g/dL; P < 0.001, albumin ≥ 3.8 g/dL vs < 3.5 g/dL; P < 0.0001, albumin 3.5-3.7 g/dL vs < 3.5; P < 0.0001); B: Platelet count (platelet ≥ 15 × 104/µL vs < 15 × 104/µL; P < 0.0001); C: Type IV collagen 7S concentration (type IV collagen 7S ≥ 5 ng/mL vs < 5 ng/mL; P < 0.0001); D: Fibrosis-4 index (Fibrosis-4 index ≥ 2.67 vs 1.3-2.67; P < 0.001, Fibrosis-4 index C1.3-2.67 vs < 1.3; P < 0.0001, Fibrosis-4 index ≥ 2.67 vs < 2.67; P < 0.0001). FIB: Fibrosis.
- Citation: Kawanaka M, Nishino K, Ishii K, Tanikawa T, Urata N, Suehiro M, Sasai T, Haruma K, Kawamoto H. Combination of type IV collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease. World J Hepatol 2021; 13(5): 571-583
- URL: https://www.wjgnet.com/1948-5182/full/v13/i5/571.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i5.571